Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis p53'

Search results for: 'research area apoptosis p53'

Items 221-230 of 243

Page
per page
  1. AS 602801
    A3189 AS 602801
    Summary: Jun Kinase Inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.45 mg/mL
  2. LY2857785
    B8002 LY2857785
    Summary: CDK9 inhibitor
  3. AM 114
    A8163 AM 114
     2 Citation
    Target: Proteasome
    Summary: 20S proteasome inhibitor
      insoluble in H2O; ≥16.65 mg/mL
  4. YM-155 hydrochloride
    A3947 YM-155 hydrochloride
    Summary: Potent survivin inhibitor
      ≥19.45 mg/mL
  5. Alendronate sodium
    A8359 Alendronate sodium
    Summary: Osteoclast-mediated bone resorption inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥15 mg/mL
  6. Toyocamycin
    B7795 Toyocamycin
    Target: phosphatidylinositol kinase
    Summary: Adenosine analog,antitumor antibiotic
      ≥77 mg/mL
  7. WP1130
    A8323 WP1130
     1 Citation
    Summary: Deubiquitinase (DUB) inhibitor, Cell permeable
      ≥38.4 mg/mL
  8. Tanshinone IIA
    N1846 Tanshinone IIA
    Target: AP-1|MAGL
    Summary: Antioxidant and anti-inflammatory reagent
      insoluble in EtOH; insoluble in H2O; ≥3.42 mg/mL
  9. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  10. YK-4-279
    A3946 YK-4-279
    Target: RHA
    Summary: RNA Helicase A (RHA) inhibitor
      insoluble in H2O; ≥16.35 mg/mL

Items 221-230 of 243

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 23item
  2. Apoptosis 146item
  3. Chromatin/Epigenetics 17item
  4. Metabolism 7item
  5. MAPK Signaling 3item
  6. Tyrosine Kinase 10item
  7. DNA Damage/DNA Repair 9item
  8. PI3K/Akt/mTOR Signaling 3item
  9. Microbiology & Virology 2item
  10. Cell Cycle/Checkpoint 8item
  11. Ubiquitination/ Proteasome 7item
  12. JAK/STAT Signaling 6item
  13. TGF-β / Smad Signaling 2item
  14. Angiogenesis 2item
  15. GPCR/G protein 1 item
  16. Stem Cell 1 item
  17. Membrane Transporter/Ion Channel 1 item
  18. Cancer Biology 21item
  19. Endocrinology and Hormones 14item
  20. Neuroscience 11item
  21. Obesity, Appetite Control & Diabetes 4item
  22. Other Signal Transduction 24item
  23. Others 12item
  24. Immunology/Inflammation 10item
  25. Cardiovascular 14item
Specificity
  1. Selective 58item
Reversibility
  1. Reversible 2item
  2. Irreversible 6item
Target
  1. Caspases 11item
  2. Cyclin-Dependent Kinases 2item
  3. Proteasome 3item
  4. Histone Deacetylases (HDACs) 4item
  5. Inhibitor of apoptosis proteins (IAP) 2item
  6. Bcl-2 5item
  7. Raf 2item
  8. Aurora Kinases 1 item
  9. Bcl-xl 2item
  10. MDM2 2item
  11. AP-1 1 item
  12. DT-diaphorases 1 item
  13. GSK-3 1 item
  14. VEGFR 3item
  15. PDGFR 2item
  16. c-Kit 2item
  17. RET 1 item
  18. Mcl-1 2item
  19. Thymidylate Synthase 1 item
  20. JNK 1 item
  21. Nrf2 1 item
  22. Sir2-like Family Deacetylases (Sirtuins) 2item
  23. Deubiquitinating enzymes (DUBs) 1 item
  24. Aminopeptidases 1 item
  25. STAT 1 item
  26. RIP kinases 1 item
  27. JAK 3item
  28. HSP90 1 item
  29. Topoisomerases 1 item
  30. Survivin 1 item
  31. Ubiquitin-specific proteases 1 item
  32. SMYD2 1 item
  33. Melanocortin (MC) Receptors 1 item
  34. MK2 1 item
  35. Fatty-acid-binding proteins (FABPs) 1 item
  36. Autophagy 1 item
  37. COX 1 item
  38. NADPH Oxidases 1 item
  39. MAGL 1 item
  40. Histamine H1 Receptors 1 item
  41. iNOS 1 item
  42. TRP Channel 1 item
  43. Apoptosis Inducers 1 item
  44. Glucocorticoid Receptors 1 item
  45. Cdc7 1 item
  46. angiogenesis 1 item
  47. c-RET 1 item
  48. FPTase 1 item
  49. sodium channels 1 item
  50. p53-MDM2 interaction 2item
  51. p53 7item
  52. cysteine protease 1 item
  53. HDM2 ubiquitin ligase 1 item
  54. PC-PLC 1 item
  55. HIV 1 item
  56. Histone Acetyltransferases (HATs) 1 item
  57. Telomerases 1 item
  58. Tyrosinases 1 item
  59. HSP70 1 item
  60. phosphatidylinositol kinase 1 item
  61. MDMX 1 item
  62. Adenosine Deaminases 1 item
  63. p21 1 item
  64. DHFR 1 item
  65. GARFT 1 item
  66. RHA 1 item
  67. TRPC channel 1 item
  68. PKD 1 item
  69. Bcl-w 1 item
  70. Sirtuin 1 item
  71. Bax 1 item
  72. NS3/4a Proteases 1 item
Reported Experiments
  1. Animal Experiments 76item
  2. Cell Experiments 68item
Related Disease
  1. Autoimmune Diseases 1 item
  2. Breast Cancer 10item
  3. Cancer 48item
  4. Chronic Lymphocytic Leukemia 1 item
  5. Chronic Myeloproliferative Disorders 1 item
  6. Colon Cancer 5item
  7. Colon Carcinoma 1 item
  8. Colorectal Cancer 3item
  9. Glioblastoma 4item
  10. HCV 1 item
  11. Hepatocellular Carcinoma 1 item
  12. Inflammatory Diseases 2item
  13. Leukemia 1 item
  14. Lung Cancer 2item
  15. Lymphoma 4item
  16. Melanoma 4item
  17. Multiple Myeloma 1 item
  18. Myelofibrosis 1 item
  19. Myeloma 1 item
  20. Neuroblastoma 1 item
  21. Non-small Cell Lung Cancer 2item
  22. Ovarian Cancer 1 item
  23. Pain Relief 1 item
  24. Pancreatic Cancer 3item
  25. Pentacyclic Triterpenoid 1 item
  26. Prostate Cancer 7item
  27. Pulmonary Fibrosis 1 item
  28. Rheumatoid Arthritis 2item
  29. Soft Tissue Sarcoma 1 item
  30. Testicular Cancer 1 item
  31. Type 2 Diabetes 2item